Brendan Smith
Stock Analyst at TD Cowen
(0)
# 4719
Out of 5,234 analysts
8
Total ratings
33.33%
Success rate
-19.72%
Average return
Main Sectors:
Top Industries:
Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
Ginkgo Bioworks Hold... | Maintains: Strong Buy | 3 10 | 11.56 | -13.49% | 1 | Sep 20, 2024 | |
Exscientia | Downgrades: Hold | n/a | n/a | n/a | 2 | Aug 9, 2024 | |
Halozyme Therapeutic... | Maintains: Strong Buy | 59 65 | 50.46 | 28.81% | 2 | Aug 7, 2024 | |
Novavax | Maintains: Hold | 5 10 | 9.74 | 2.67% | 1 | May 13, 2024 | |
Arrowhead Pharma | Initiates Coverage On: Outperform | n/a | n/a | n/a | 1 | Jul 21, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | n/a | n/a | n/a | 1 | Dec 5, 2022 |